The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
PLGA in situ implants formed by phase inversion: Critical physicochemical parameters to modulate drug release
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Handbook of Pharmaceutical Excipients
Rowe, R. C., Sheskey, P. J., & Quinn, M. E. (1994) · Cited by 3,493
Mechanisms of polymer degradation and erosion
Göpferich, A. (1996) · Biomaterials · doi:10.1016/0142-9612(96)85755-3 · Cited by 1,781
Solubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,415
Biodegradable polymers for use in surgery—polyglycolic/poly(actic acid) homo- and copolymers: 1
Gilding, D. K., & Reed, A. M. (1979) · Polymer · doi:10.1016/0032-3861(79)90009-0 · Cited by 1,345
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review
Fredenberg, S., Wahlgren, M., Reslow, M., & Axelsson, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.049 · Cited by 1,286
Chemical syntheses of biodegradable polymers
Okada, M. (2002) · Progress in Polymer Science · doi:10.1016/s0079-6700(01)00039-9 · Cited by 1,199
Why degradable polymers undergo surface erosion or bulk erosion
Burkersroda, F. V., Schedl, L., & Göpferich, A. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00170-9 · Cited by 1,146
Nanotechnology: Intelligent Design to Treat Complex Disease
Couvreur, P., & Vauthier, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0284-8 · Cited by 948
Current advances in research and clinical applications of PLGA-based nanotechnology
Lü, J.-M., Wang, X., Marin-Muller, C., Wang, H., Lin, P. H., Yao, Q., & Chen, C. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.15 · Cited by 903
Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence
Grizzi, I., Garreau, H., Li, S., & Vert, M. (1995) · Biomaterials · doi:10.1016/0142-9612(95)93258-f · Cited by 895
Biodegradable injectable in situ forming drug delivery systems
Hatefi, A., & Amsden, B. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00008-1 · Cited by 726
Li, S. (1999) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(1999)48:3<342::aid-jbm20>3.0.co;2-7 · Cited by 664
Degradation of poly(lactic-co-glycolic acid) microspheres: Effect of copolymer composition
Park, T. G. (1995) · Biomaterials · doi:10.1016/0142-9612(95)93575-x · Cited by 642
Analysis of Data on the Medicament Release from Ointments
Higuchi, W. I. (1962) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600510825 · Cited by 600
de Jong, S. J., Arias, E. R., Rijkers, D. T. S., van Nostrum, C. F., Kettenes-van den Bosch, J. J., & Hennink, W. E. (2001) · Polymer · doi:10.1016/s0032-3861(00)00646-7 · Cited by 414
In situ forming parenteral drug delivery systems: an overview
Packhaeuser, C. B., Schnieders, J., Oster, C. G., & Kissel, T. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.003 · Cited by 413
Tracy, M. (1999) · Biomaterials · doi:10.1016/s0142-9612(99)00002-2 · Cited by 411
One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate
Okada, H. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00050-1 · Cited by 371
Faisant, N., Siepmann, J., & Benoit, J. P. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00023-4 · Cited by 346
Pore formation mechanism of membranes from phase inversion process
Young, T.-H., & Chen, L.-W. (1995) · Desalination · doi:10.1016/0011-9164(95)00076-3 · Cited by 340
In situ forming implants — an attractive formulation principle for parenteral depot formulations
Kempe, S., & Mäder, K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.016 · Cited by 323
Wu, X. S., & Wang, N. (2001) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856201744425 · Cited by 317
Handbook of Pharmaceutical Excipients
Press, P. (2012) · Pharmacy Practice · Cited by 235
McKelvey, S. (1996) · Journal of Membrane Science · doi:10.1016/0376-7388(95)00197-2 · Cited by 231
Phase inversion dynamics of PLGA solutions related to drug delivery
Graham, P. D., Brodbeck, K. J., & McHugh, A. J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00158-8 · Cited by 222
The controlled parenteral delivery of polypeptides and proteins
PITT, C. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90108-g · Cited by 190
Eligard: leuprolide acetate in a novel sustained-release delivery system
Sartor, O. (2003) · Urology · doi:10.1016/s0090-4295(02)02396-8 · Cited by 183
Phase inversion dynamics of PLGA solutions related to drug delivery
Brodbeck, K. J., DesNoyer, J. R., & McHugh, A. J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00159-5 · Cited by 174
Mapping neutral microclimate pH in PLGA microspheres
Li, L., & Schwendeman, S. P. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.029 · Cited by 167
Raman, C., Berkland, C., Kim, K. (., & Pack, D. W. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.11.012 · Cited by 166 · cited 1×
“Smallorhydrophobicdrugs,however,canef fi cientlydiffusethrough the polymer-rich and even the hardened polymer phase into the aqueous surrounding [47].”
BackgroundInjectable implants for the sustained release of protein and peptide drugs
Agarwal, P., & Rupenthal, I. D. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.01.013 · Cited by 147
Effect of injection site on in situ implant formation and drug release in vivo
Patel, R. B., Solorio, L., Wu, H., Krupka, T. M., & Exner, A. A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.020 · Cited by 134
A novel in situ forming drug delivery system for controlled parenteral drug delivery
Kranz, H., & Bodmeier, R. A. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.09.033 · Cited by 134
Luan, X., & Bodmeier, R. A. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.10.005 · Cited by 130
Jain, R. A. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00062-x · Cited by 130
Tang, Y., & Singh, J. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.053 · Cited by 120
Lambert, W. J., & Peck, K. D. (1995) · Journal of Controlled Release · doi:10.1016/0168-3659(94)00083-7 · Cited by 113
Li, S., & Vert, M. (1994) · Macromolecules · doi:10.1021/ma00089a031 · Cited by 112
Fredericks, R. J., Melveger, A. J., & Dolegiewitz, L. J. (1984) · Journal of Polymer Science Polymer Physics Edition · doi:10.1002/pol.1984.180220106 · Cited by 112
Sustained Release of Human Growth Hormone from PLGA Solution Depots
Brodbeck, K. J., Pushpala, S., & McHugh, A. J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018943107688 · Cited by 110
Biocompatibility of a biodegradablein situ forming implant system in rhesus monkeys
Royals, M. A., Fujita, S. M., Yewey, G. L., Rodriguez, J., Schultheiss, P. C., & Dunn, R. L. (1999) · Journal of Biomedical Materials Research · Cited by 110
Schwach, G., & Vert, M. (1999) · International Journal of Biological Macromolecules · doi:10.1016/s0141-8130(99)00043-4 · Cited by 109
Gad, H. A., El-Nabarawi, M. A., & ElHady, S. S. A. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-008-9126-9 · Cited by 105
Controlled delivery of testosterone from smart polymer solution based systems: In vitro evaluation
Chen, S., & Singh, J. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.02.023 · Cited by 104
Liu, Q., Zhang, H., Zhou, G., Xie, S.-B., Zou, H. L., Yu, Y., Li, G., Sun, D., Zhang, G., Lü, Y., et al. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.015 · Cited by 96
Myotoxicity studies of injectable biodegradable in-situ forming drug delivery systems
Kranz, H. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00568-8 · Cited by 96
Recent advances in polymeric microspheres for parenteral drug delivery – part 1
Mao, S., Guo, C., Shi, Y., & Li, L. C. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.709844 · Cited by 92
Astaneh, R., Erfan, M., Moghimi, H., & Mobedi, H. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21415 · Cited by 91
Enhancement of carboplatin toxicity by Pluronic block copolymers
Exner, A. A., Krupka, T. M., Scherrer, K., & Teets, J. M. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.015 · Cited by 88
Parameters affecting the efficacy of a sustained release polymeric implant of leuprolide
Ravivarapu, H. B., Moyer, K. L., & Dunn, R. L. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00371-3 · Cited by 86
Kempe, S., Metz, H., & Mäder, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.06.006 · Cited by 84
Camargo, J. A., Sapin‐Minet, A., Nouvel, C., Daloz, D., Léonard, M., Bonneaux, F., Six, J., & Maincent, P. (2012) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.660952 · Cited by 84
Self-citationNoninvasive characterization of in situ forming implants using diagnostic ultrasound
Solorio, L., Babin, B. M., Patel, R. B., Mach, J., Azar, N., & Exner, A. A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.001 · Cited by 81
Luan, X., & Bodmeier, R. A. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.09.002 · Cited by 77
The effect of Pluronic on the protein release kinetics of an injectable drug delivery system
DesNoyer, J. R., & McHugh, A. J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00293-6 · Cited by 76
PLGA Erosion: Solubility- or Diffusion-Controlled?
Körber, M. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0232-5 · Cited by 74
Tae, G., Kornfield, J. A., & Hubbell, J. A. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.01.042 · Cited by 73
Effect of excipients on PLGA film degradation and the stability of an incorporated peptide
Houchin, M. L., Neuenswander, S. A., & Topp, E. M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.11.023 · Cited by 72
Wang, L., Wang, A., Zhao, X., Liu, X., Wang, D., Sun, F., & Li, Y. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.02.015 · Cited by 72
Patel, R. B., Carlson, A. N., Solorio, L., & Exner, A. A. (2010) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32724 · Cited by 71
In Vitro and In Vivo Drug Release from a Novel In Situ Forming Drug Delivery System
Kranz, H., Yilmaz, E., Brazeau, G. A., & Bodmeier, R. A. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9478-y · Cited by 69
Kempe, S., Metz, H., Pereira, P. G. C., & Mäder, K. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.008 · Cited by 66
Smart Polymers for Controlled Delivery of Proteins and Peptides: A Review of Patents
Fogueri, L. R., & Singh, S. (2009) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221109787158300 · Cited by 65
Development of PLGA-Based Injectable Delivery Systems For Hydrophobic Fenretinide
Wischke, C., Zhang, Y., Mittal, S., & Schwendeman, S. P. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0202-y · Cited by 64
Bakhshi, R., Vasheghani‐Farahani, E., Mobedi, H., Jamshidi, A., & Khakpour, M. (2006) · Polymers for Advanced Technologies · doi:10.1002/pat.717 · Cited by 63
Solorio, L., Olear, A. M., Hamilton, J., Patel, R. B., Beiswenger, A. C., Wallace, J. E., Zhou, H., & Exner, A. A. (2012) · Theranostics · doi:10.7150/thno.4181 · Cited by 61
Robust and prolonged gene expression from injectable polymeric implants
Eliaz, R. E., & Szoka, F. C. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301786 · Cited by 56
Delivery of Soluble Tumor Necrosis Factor Receptor from In-Situ Forming PLGA Implants: In-Vivo
Eliaz, R. E., Wallach, D. S., & Kost, J. (2000) · Pharmaceutical Research · doi:10.1023/a:1007621512647 · Cited by 53
Ahmed, T. A., Ibrahim, H. M., Ibrahim, F., Samy, A. M., Kassem, A. A., Nutan, M. T. H., & Hussain, M. D. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23250 · Cited by 53
In vitro release of insulin and biocompatibility of in situ forming gel systems
Kang, F., & Singh, J. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.07.024 · Cited by 48
In situ forming implant for controlled delivery of an anti-HIV fusion inhibitor
Kapoor, D. N., Katare, O. P., & Dhawan, S. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.01.005 · Cited by 47
Renard, P. L., Buchegger, F., Petri‐Fink, A., Bosman, F. T., Rüfenacht, D. A., Hofmann, H., Doelker, É., & Jordan, O. (2009) · International Journal of Hyperthermia · doi:10.1080/02656730802713557 · Cited by 44
Chen, S., & Singh, J. (2005) · Pharmaceutical Development and Technology · doi:10.1081/pdt-54479 · Cited by 43
Chhabra, S., Sachdeva, V., & Singh, S. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.04.034 · Cited by 40
Schoenhammer, K., Petersen, H., Guethlein, F., & Göpferich, A. M. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.12.019 · Cited by 39
Development of an in situ forming PLGA drug delivery system
Körber, M., & Bodmeier, R. A. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.07.007 · Cited by 38
Interdependency of protein-release completeness and polymer degradation in PLGA-based implants
Ghalanbor, Z., Körber, M., & Bodmeier, R. A. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.03.031 · Cited by 37
Injectable, in situ forming poly(propylene fumarate)‐based ocular drug delivery systems
Ueda, H., Hacker, M. C., Haesslein, A., Jo, S., Ammon, D. M., Borazjani, R. N., Künzler, J., Salamone, J. C., & Mikos, A. G. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31226 · Cited by 37
Zare, M., Mobedi, H., Barzin, J., Mivehchi, H., Jamshidi, A., & Mashayekhi, R. (2007) · Journal of Applied Polymer Science · doi:10.1002/app.27520 · Cited by 36
Qin, Y., Yuan, M., Li, L., Li, W., & Xue, J. (2012) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.32788 · Cited by 35
Poly(ethyleneglycol) 500 Dimethylether as Novel Solvent for Injectable In Situ Forming Depots
Schoenhammer, K., Petersen, H., Guethlein, F., & Göpferich, A. M. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9969-0 · Cited by 33
Controlled and sustained gene delivery from injectable, porous PLGA scaffolds
Jeon, O., Krebs, M. D., & Alsberg, E. (2011) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.33098 · Cited by 32
DesNoyer, J. R., & McHugh, A. J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00354-0 · Cited by 32
Chen, F., Kuriakose, M. A., Zhou, M., DeLacure, M. D., & Dunn, R. L. (2003) · Head & Neck · doi:10.1002/hed.10241 · Cited by 30
Prabhu, S. V., Tran, L. P., & Betageri, G. V. (2005) · Drug Delivery · doi:10.1080/10717540590968873 · Cited by 30
Krupka, T. M., Weinberg, B. D., Ziats, N. P., Haaga, J. R., & Exner, A. A. (2006) · Investigative Radiology · doi:10.1097/01.rli.0000246102.56801.2f · Cited by 29
Voigt, M., Koerber, M., & Bodmeier, R. A. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.05.029 · Cited by 28
Self-citationAn in situ-forming, solid lipid/PLGA hybrid implant for long-acting antipsychotics
Dong, S., Wang, S., Zheng, C., Liang, W., & Huang, Y. (2011) · Soft Matter · doi:10.1039/c1sm05310h · Cited by 27
Gyulai, G., Pénzes, C. B., Mohai, M., Lohner, T., Petrík, P., Kurunczi, S., & Kiss, É. (2011) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2011.06.055 · Cited by 25
Dernell, W. S., Straw, R. C., Withrow, S. J., et al. (1998) · Journal of drug targeting · doi:10.3109/10611869808997866 · Cited by 22
Biocompatibility of an Injectable In Situ Forming Depot for Peptide Delivery
Schoenhammer, K., Boisclair, J., Schuetz, H., Petersen, H., & Göpferich, A. M. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22149 · Cited by 22
Development and Evaluation of In Situ Gel-forming System for Sustained Delivery of Insulin
Dhawan, S., Kapil, R., & Kapoor, D. N. (2010) · Journal of Biomaterials Applications · doi:10.1177/0885328209359959 · Cited by 20
Asmus, L. R., Gurny, R., & Möller, M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.07.007 · Cited by 18
Mashak, A., Mobedi, H., Ziaee, F., & Nekoomanesh, M. (2010) · Polymer Bulletin · doi:10.1007/s00289-010-0386-7 · Cited by 16
Asmus, L. R., Tille, J., Kaufmann, B., Melander, L., Weiss, T., Vessman, K., Koechling, W., Schwach, G., Gurny, R., & Möller, M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.11.014 · Cited by 16
Optimized Preparation of in Situ Forming Microparticles for the Parenteral Delivery of Vinpocetine
Li, J., Chen, F., Hu, C.-J., He, L., Yan, K., Zhou, L., & Pan, W. (2008) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.56.796 · Cited by 15
Yehia, S. A., Elshafeey, A. H., & Elsayed, I. (2011) · Journal of Liposome Research · doi:10.3109/08982104.2011.631141 · Cited by 14
Rafienia, M., Emami, S. H., Mirzadeh, H., Mobedi, H., & Karbasi, S. (2009) · Current Drug Delivery · doi:10.2174/156720109787846243 · Cited by 12
In Situ Micro‐Sized Gel‐Forming Injectable Implant Using Biodegradable Amphiphilic Graft Copolymer
Cho, K. Y., Lee, S., & Park, J. (2007) · Macromolecular Bioscience · doi:10.1002/mabi.200700045 · Cited by 9
Stereoselective behavior of a novel biodegradable racemic ketoprofen injectable implant in rats
Wang, S., Yin, L., Liang, Z., Lu, S., & Zeng, S. (2007) · Chirality · doi:10.1002/chir.20453 · Cited by 6
Cited by
Xu, Y., Kim, C., Saylor, D. M., & Koo, D. (2017) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.33648 · Cited by 424
Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation
Park, K., Skidmore, S., Hadar, J., Garner, J., Park, H., Otte, A., Soh, B. K., Yoon, G., Yu, D., Yun, Y., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.003 · Cited by 404
Recent Applications of PLGA in Drug Delivery Systems
Yang, J., Zeng, H., Luo, Y., Chen, Y., Wang, M., Wu, C., & Hu, P. (2024) · Polymers · doi:10.3390/polym16182606 · Cited by 268
Zhou, H., He, Z., Cao, Y., Chu, L., Liang, B., Yu, K., & Deng, Z. (2024) · Theranostics · doi:10.7150/thno.97412 · Cited by 115
Analysis of the effect of HDAC inhibitors on the formation of the HIV reservoir
Ling, L., Kim, M., Soper, A., Kovarova, M., Spagnuolo, R. A., Begum, N., Kirchherr, J., Archin, N., Battaglia, D., Cleveland, D., et al. (2024) · mBio · doi:10.1128/mbio.01632-24 · Cited by 14
Metadata
- Authors
- Parent, M., Nouvel, C., Koerber, M., Sapin, A., Maincent, P., & Boudier, A.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 172
- Issue
- 1
- Pages
- 292-304
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W1994620171
- Cited by
- 263
- References
- 100
- FWCI
- 7.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.